表紙:核医学の世界市場 - 2026年までの予測:製品 (診断製品・治療製品)・アプリケーション (骨転移・心臓病学・内分泌腫瘍・リンパ腫・腫瘍学) 別、COVID-19の累積的影響
市場調査レポート
商品コード
973204

核医学の世界市場 - 2026年までの予測:製品 (診断製品・治療製品)・アプリケーション (骨転移・心臓病学・内分泌腫瘍・リンパ腫・腫瘍学) 別、COVID-19の累積的影響

Nuclear Medicine Market Research Report by Product, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 185 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円
核医学の世界市場 - 2026年までの予測:製品 (診断製品・治療製品)・アプリケーション (骨転移・心臓病学・内分泌腫瘍・リンパ腫・腫瘍学) 別、COVID-19の累積的影響
出版日: 2021年06月01日
発行: 360iResearch LLP
ページ情報: 英文 185 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界における核医学の市場規模は、2019年の38億1267万米ドルから、2025年末までに57億138万米ドルへ拡大すると予測され、6.93%のCAGRが見込まれています。

当レポートでは、世界の核医学市場について取り上げ、市場ダイナミクス、競合環境、各セグメント・地域別の市場、競合状況、および主要企業などについて詳細に分析しています。

目次

第1章 序文

  • 調査の目的
  • 市場セグメンテーション&範囲
  • 調査対象年度
  • 通貨&価格
  • 言語
  • ステークホルダー

第2章 調査手法

  • 調査プロセス
    • 定義:調査目的
    • 決定:調査設計
    • 準備:調査機器
    • 収集:データソース
    • 分析:データの解釈
    • 策定:データ検証
    • 発行: 調査報告書
    • 繰り返し:レポートの更新
  • 調査実施
    • 開始:調査プロセス
    • 計画:調査計画の策定
    • 実行:調査の実施
    • 検証:検索と分析
    • 出版物:調査報告
  • 調査結果

第3章 エグゼクティブサマリー

  • イントロダクション
  • 市場の展望
  • 製品の展望
  • アプリケーションの展望
  • 地域の展望
  • 競合企業の展望

第4章 市場概要

  • イントロダクション

第5章 市場力学

  • イントロダクション
  • 促進要因
  • 抑制要因
  • 市場機会
  • 課題

第6章 市場考察

  • ポーターのファイブフォース分析
  • COVID-19の累積的影響
  • クライアントのカスタマイズ

第7章 世界の核医学市場:製品別

  • イントロダクション
  • 診断製品
    • PET
    • SPECT
  • 治療製品
    • アルファエミッター
    • ベータエミッター
    • 小線源治療

第8章 世界の核医学市場:アプリケーション別

  • イントロダクション
  • 骨転移
  • 心臓病学
  • 内分泌腫瘍
  • リンパ腫
  • 腫瘍学
  • 甲状腺

第9章 南北アメリカの核医学市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋の核医学市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • 韓国
  • タイ

第11章 欧州、中東・アフリカの核医学市場

  • イントロダクション
  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリックス
  • 市場ランキング分析
  • 市場シェア分析
  • 競合シナリオ

第13章 企業のユーザビリティプロファイル

  • Australian Nuclear Science & Technology Organization (ANSTO)
  • Bracco Imaging S.p.A
  • Curium Pharma
  • Eckert & Ziegler
  • Eczacibasi-Monrol
  • GE Healthcare
  • Jubilant Pharma. LLC
  • Lantheus Medical Imaging, Inc.
  • Mallinckrodt
  • Nordion (Canada) Inc.
  • NTP Radioisotopes SOC Ltd.
  • The Institute for Radioelements (IRE - IRE ELiT)

第14章 付録

  • ディスカッションガイド
図表

LIST OF FIGURES

  • FIGURE 1. GLOBAL NUCLEAR MEDICINE MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL NUCLEAR MEDICINE MARKET: MARKET DYNAMICS
  • FIGURE 6. GLOBAL NUCLEAR MEDICINE MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 7. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
  • FIGURE 8. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
  • FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2026
  • FIGURE 10. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2026 (USD MILLION)
  • FIGURE 11. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 12. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2026 (USD MILLION)
  • FIGURE 13. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 14. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY F-18, 2018-2026 (USD MILLION)
  • FIGURE 15. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY F-18, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 16. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SR-82/RB-82, 2018-2026 (USD MILLION)
  • FIGURE 17. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SR-82/RB-82, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 18. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2026 (USD MILLION)
  • FIGURE 19. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 20. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY GA-67, 2018-2026 (USD MILLION)
  • FIGURE 21. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY GA-67, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 22. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY I-123, 2018-2026 (USD MILLION)
  • FIGURE 23. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY I-123, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 24. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TC-99M, 2018-2026 (USD MILLION)
  • FIGURE 25. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TC-99M, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 26. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TL-201, 2018-2026 (USD MILLION)
  • FIGURE 27. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TL-201, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 28. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2026 (USD MILLION)
  • FIGURE 29. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 30. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTERS, 2018-2026 (USD MILLION)
  • FIGURE 31. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 32. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RA-223, 2018-2026 (USD MILLION)
  • FIGURE 33. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RA-223, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 34. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2026 (USD MILLION)
  • FIGURE 35. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 36. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY I-131, 2018-2026 (USD MILLION)
  • FIGURE 37. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY I-131, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 38. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY LU-117, 2018-2026 (USD MILLION)
  • FIGURE 39. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY LU-117, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 40. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RE-186, 2018-2026 (USD MILLION)
  • FIGURE 41. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RE-186, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 42. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SM-153, 2018-2026 (USD MILLION)
  • FIGURE 43. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SM-153, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 44. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY Y-90, 2018-2026 (USD MILLION)
  • FIGURE 45. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY Y-90, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 46. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2026 (USD MILLION)
  • FIGURE 47. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 48. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CESIUM-131, 2018-2026 (USD MILLION)
  • FIGURE 49. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CESIUM-131, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 50. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IODINE-125, 2018-2026 (USD MILLION)
  • FIGURE 51. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IODINE-125, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 52. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IRIDIUM-192, 2018-2026 (USD MILLION)
  • FIGURE 53. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IRIDIUM-192, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 54. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PALLADIUM-103, 2018-2026 (USD MILLION)
  • FIGURE 55. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PALLADIUM-103, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 56. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
  • FIGURE 57. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
  • FIGURE 58. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2026
  • FIGURE 59. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BONE METASTASIS, 2018-2026 (USD MILLION)
  • FIGURE 60. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BONE METASTASIS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 61. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2026 (USD MILLION)
  • FIGURE 62. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 63. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ENDOCRINE TUMOR, 2018-2026 (USD MILLION)
  • FIGURE 64. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ENDOCRINE TUMOR, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 65. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY LYMPHOMA, 2018-2026 (USD MILLION)
  • FIGURE 66. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY LYMPHOMA, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 67. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2026 (USD MILLION)
  • FIGURE 68. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 69. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THYROID, 2018-2026 (USD MILLION)
  • FIGURE 70. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THYROID, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 71. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 72. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 73. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 74. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 75. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 76. CANADA NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 77. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 78. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 79. CALIFORNIA NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 80. FLORIDA NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 81. ILLINOIS NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 82. NEW YORK NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 83. OHIO NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 84. PENNSYLVANIA NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 85. TEXAS NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 86. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 87. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 88. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 89. CHINA NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 90. INDIA NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 91. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 92. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 93. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 94. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 95. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 96. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 97. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 98. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 99. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 100. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 101. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 102. ITALY NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 103. NETHERLANDS NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 104. QATAR NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 105. RUSSIA NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 106. SAUDI ARABIA NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 107. SOUTH AFRICA NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 108. SPAIN NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 109. UNITED ARAB EMIRATES NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 110. UNITED KINGDOM NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 111. GLOBAL NUCLEAR MEDICINE MARKET: FPNV POSITIONING MATRIX
  • FIGURE 112. GLOBAL NUCLEAR MEDICINE MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 113. GLOBAL NUCLEAR MEDICINE MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 114. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL NUCLEAR MEDICINE MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL NUCLEAR MEDICINE MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY F-18, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SR-82/RB-82, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY GA-67, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY I-123, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TC-99M, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TL-201, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RA-223, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY I-131, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY LU-117, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RE-186, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SM-153, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY Y-90, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CESIUM-131, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IODINE-125, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IRIDIUM-192, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PALLADIUM-103, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BONE METASTASIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ENDOCRINE TUMOR, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY LYMPHOMA, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THYROID, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. CANADA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. CANADA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. CALIFORNIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. CALIFORNIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. FLORIDA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. FLORIDA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. ILLINOIS NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. ILLINOIS NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. NEW YORK NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. NEW YORK NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. OHIO NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. OHIO NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. PENNSYLVANIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. PENNSYLVANIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. TEXAS NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. TEXAS NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. CHINA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. CHINA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. INDIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. INDIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. JAPAN NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. MALAYSIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. PHILIPPINES NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. SOUTH KOREA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. THAILAND NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. FRANCE NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. GERMANY NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. ITALY NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. ITALY NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. NETHERLANDS NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. NETHERLANDS NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. QATAR NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. QATAR NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. RUSSIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. RUSSIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. SAUDI ARABIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. SAUDI ARABIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. SOUTH AFRICA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. SOUTH AFRICA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. SPAIN NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. SPAIN NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. UNITED ARAB EMIRATES NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. UNITED ARAB EMIRATES NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. UNITED KINGDOM NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. UNITED KINGDOM NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. GLOBAL NUCLEAR MEDICINE MARKET: SCORES
  • TABLE 107. GLOBAL NUCLEAR MEDICINE MARKET: BUSINESS STRATEGY
  • TABLE 108. GLOBAL NUCLEAR MEDICINE MARKET: PRODUCT SATISFACTION
  • TABLE 109. GLOBAL NUCLEAR MEDICINE MARKET: RANKING
  • TABLE 110. GLOBAL NUCLEAR MEDICINE MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 111. GLOBAL NUCLEAR MEDICINE MARKET: SHARE, BY COMPANY, 2020
  • TABLE 112. GLOBAL NUCLEAR MEDICINE MARKET: MERGER & ACQUISITION
  • TABLE 113. GLOBAL NUCLEAR MEDICINE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 114. GLOBAL NUCLEAR MEDICINE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 115. GLOBAL NUCLEAR MEDICINE MARKET: INVESTMENT & FUNDING
  • TABLE 116. GLOBAL NUCLEAR MEDICINE MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 117. GLOBAL NUCLEAR MEDICINE MARKET: LICENSE & PRICING
  • TABLE 118. GLOBAL NUCLEAR MEDICINE MARKET: CONTACT DETAILS
目次
Product Code: MRR-A339DAEFAF60

The Global Nuclear Medicine Market size was estimated at USD 4,198.71 Million in 2020 and expected to reach USD 4,484.62 Million in 2021, at a Compound Annual Growth Rate (CAGR) 7.14% to reach USD 6,353.63 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Nuclear Medicine to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the Nuclear Medicine Market was studied across Diagnostic Products and Therapeutic Products. The Diagnostic Products is further studied across PET and SPECT. The Therapeutic Products is further studied across Alpha Emitters, Beta Emitters, and Brachytherapy.

Based on Application, the Nuclear Medicine Market was studied across Bone Metastasis, Cardiology, Endocrine Tumor, Lymphoma, Oncology, and Thyroid.

Based on Geography, the Nuclear Medicine Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Nuclear Medicine Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Nuclear Medicine Market, including Australian Nuclear Science & Technology Organization, Bayer AG, Bracco Imaging S.P.A., BWX Technologies, Inc., Cardinal Health, Inc., Curium by CapVest Associates, Eckert & Ziegler Group, Eczacibasi-Monrol Nuclear Products, GE Healthcare, Global Medical Solutions, Ltd., IBA Molecular, Institute of Isotopes Co., Ltd., Isotopia Molecular Imaging Limited, Joint Stock Company Isotope, Jubilant Draximage, Inc., Lantheus Medical Imaging, Inc., Medtronic, Inc, Nordion, Inc, Northstar Medical Radioisotopes, LLC, Novartis AG, NTP Radioisotopes Soc, Ltd., PharmaLogic Holdings Corp, Shine Medical Technologies, and Sinotau Pharmaceuticals Group.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Nuclear Medicine Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Nuclear Medicine Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Nuclear Medicine Market?
  • 4. What is the competitive strategic window for opportunities in the Global Nuclear Medicine Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Nuclear Medicine Market?
  • 6. What is the market share of the leading vendors in the Global Nuclear Medicine Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Nuclear Medicine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Product Outlook
  • 3.4. Application Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of procedures to diagnose and treat cancer
      • 5.1.1.2. Application of alpha radioimmunotherapy-based targeted cancer treatment
      • 5.1.1.3. Rising demand for better medical solutions
    • 5.1.2. Restraints
      • 5.1.2.1. Short half-life of nuclear medicine
    • 5.1.3. Opportunities
      • 5.1.3.1. Nuclear pharmaceuticals used in neurological applications
      • 5.1.3.2. Rising approach to measure in vivo physiology, biochemistry, and metabolism
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness about the related benefits among patients, physician education, and awareness
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Nuclear Medicine Market, by Product

  • 6.1. Introduction
  • 6.2. Diagnostic Products
    • 6.2.1. PET
      • 6.2.1.1. F-18
      • 6.2.1.2. SR-82/RB-82
    • 6.2.2. SPECT
      • 6.2.2.1. GA-67
      • 6.2.2.2. I-123
      • 6.2.2.3. TC-99m
      • 6.2.2.4. TL-201
  • 6.3. Therapeutic Products
    • 6.3.1. Alpha Emitters
      • 6.3.1.1. RA-223
    • 6.3.2. Beta Emitters
      • 6.3.2.1. I-131
      • 6.3.2.2. Lu-117
      • 6.3.2.3. Re-186
      • 6.3.2.4. SM-153
      • 6.3.2.5. Y-90
    • 6.3.3. Brachytherapy
      • 6.3.3.1. Cesium-131
      • 6.3.3.2. Iodine-125
      • 6.3.3.3. Iridium-192
      • 6.3.3.4. Palladium-103

7. Nuclear Medicine Market, by Application

  • 7.1. Introduction
  • 7.2. Bone Metastasis
  • 7.3. Cardiology
  • 7.4. Endocrine Tumor
  • 7.5. Lymphoma
  • 7.6. Oncology
  • 7.7. Thyroid

8. Americas Nuclear Medicine Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States
    • 8.6.1. California
    • 8.6.2. Florida
    • 8.6.3. Illinois
    • 8.6.4. New York
    • 8.6.5. Ohio
    • 8.6.6. Pennsylvania
    • 8.6.7. Texas

9. Asia-Pacific Nuclear Medicine Market

  • 9.1. Introduction
  • 9.2. China
  • 9.3. India
  • 9.4. Indonesia
  • 9.5. Japan
  • 9.6. Malaysia
  • 9.7. Philippines
  • 9.8. South Korea
  • 9.9. Thailand

10. Europe, Middle East & Africa Nuclear Medicine Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Quadrant
  • 11.4. Market Share Analysis, By Company
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Australian Nuclear Science & Technology Organization
  • 12.2. Bayer AG
  • 12.3. Bracco Imaging S.P.A.
  • 12.4. BWX Technologies, Inc.
  • 12.5. Cardinal Health, Inc.
  • 12.6. Curium by CapVest Associates
  • 12.7. Eckert & Ziegler Group
  • 12.8. Eczacibasi-Monrol Nuclear Products
  • 12.9. GE Healthcare
  • 12.10. Global Medical Solutions, Ltd.
  • 12.11. IBA Molecular
  • 12.12. Institute of Isotopes Co., Ltd.
  • 12.13. Isotopia Molecular Imaging Limited
  • 12.14. Joint Stock Company Isotope
  • 12.15. Jubilant Draximage, Inc.
  • 12.16. Lantheus Medical Imaging, Inc.
  • 12.17. Medtronic, Inc
  • 12.18. Nordion, Inc
  • 12.19. Northstar Medical Radioisotopes, LLC
  • 12.20. Novartis AG
  • 12.21. NTP Radioisotopes Soc, Ltd.
  • 12.22. PharmaLogic Holdings Corp
  • 12.23. Shine Medical Technologies
  • 12.24. Sinotau Pharmaceuticals Group

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
  • 13.3. Contact Details